Peter Grant had an executive career spanning 40 years, nearly half at listed company board level. His executive career included CEO of Skyepharma PLC, CFO of Skyepharma PLC, Group Finance Director at Eurodis Electron PLC, CFO at WorldPay Group plc, Group Chief Executive at Molins PLC and Finance Director at Molins PLC. Prior to this he held a variety of senior commercial, financial and general management roles in the General Electric Company PLC group of companies. He holds an MA in Mathematics from the University of Oxford and is a Chartered Accountant. Peter is currently Chairman of LiDCO Group Plc, and a Non-Executive Director of Labatec Pharma SA. Peter joined the Board of Microsaic on 1 January 2018. In addition to chairing the Board, Peter chairs the Finance and Audit Committee and is a member of the Remuneration Committee of the Company.

Glenn has more than 20 years’ experience leading product marketing and R&D for small and large companies in sensing and detection, across applications in human and environmental health. For the majority of this time, Glenn was at global life sciences company PerkinElmer, where he progressed through multiple senior roles advancing PerkinElmer’s environmental health technologies from high-end laboratory detection to field-based sensing across a number of markets such as food, air, water and pharmaceuticals. Glenn joined the Company in March 2015 and was appointed to the Board on December 1 2015.

Bevan Metcalf has 35 years’ of financial management experience with international companies primarily in the mining and pharmaceuticals sectors, including Beowulf Mining (2014-2017), Afferro Mining (2008-2013), African Eagle Resources (2004-2011), Orion Corporation (1995-2003) and GlaxoSmithKline (1984-1995). In the past ten years, he has been involved with companies listed on the AIM market of the London Stock Exchange and on the Toronto stock exchange as Finance Director, Chief Financial Officer and in a non-executive director capacity. Bevan is a Member of the Chartered Accountants – Australia and New Zealand, and he has a degree in Management Studies from the University of Waikato, New Zealand. Bevan was appointed to the Board of the Company on 18 December 2015.

Christopher Buckley has more than 30 years of international marketing and general management experience in the global Pharmaceutical industry with a proven track record of translating scientific innovations into competitive customer-focused benefits. Most recently, he was a Global Brand Director at Novartis, at which he spent the majority of his career progressing through a variety of local, regional and global roles. He brings Microsaic a wealth of strategic management experience, coupled with the pragmatic and commercial expertise to effectively grow global brands. Mr Buckley holds a B.Sc. Hons in Pharmacology and Physiology from the University of Aston, UK. Christopher was appointed to the Board of the Company on 1 April 2016 as a Non-Executive Director. In addition Mr Christopher Buckley, Non-Executive Director, is a member of the Finance and Audit Committee and the Remuneration Committee.

Andrew Holmes is Professor of Micro-Electro-Mechanical Systems at Imperial College London and a co-founder of the Company. Professor Holmes was educated at Cambridge University and Imperial College London, and specialises in research into microfabrication and micropower technologies. Andrew has been Company Secretary since 2004 and is a member of the Finance and Audit Committee and the Board's Remuneration Committee.

Eric Yeatman is Professor of Micro-Engineering at Imperial College London and was appointed Head of the Department of Electrical and Electronic Engineering in September 2015. Eric is a co-founder of the Company. He chairs the Remuneration Committee and sits on the Board's Finance and Audit Committee. Eric was educated at Dalhousie University (Halifax, Canada) and Imperial College London. He specialises in micro-systems research and has acted as an advisor to two venture capital funds.

Eric has held the following roles within the Company:

• Chairman: 2004 – December 2011
• Interim CEO: December 2011 – November 2012
• Chairman: November 2012 – June 2013
• Non-Executive Director: June 2013 – February 2017
• Interim Chairman: February 2017 – December 2017
• Non-Executive Director: January 2018 to date

Glenn has more than 20 years’ experience leading product marketing and R&D for small and large companies in sensing and detection, across applications in human and environmental health. For the majority of this time, Glenn was at global life sciences company PerkinElmer, where he progressed through multiple senior roles advancing PerkinElmer’s environmental health technologies from high-end laboratory detection to field-based sensing across a number of markets such as food, air, water and pharmaceuticals. Glenn joined the Company in March 2015 and was appointed to the Board on December 1 2015.

Bevan Metcalf has 35 years’ of financial management experience with international companies primarily in the mining and pharmaceuticals sectors, including Beowulf Mining (2014-2017), Afferro Mining (2008-2013), African Eagle Resources (2004-2011), Orion Corporation (1995-2003) and GlaxoSmithKline (1984-1995). In the past ten years, he has been involved with companies listed on the AIM market of the London Stock Exchange and on the Toronto stock exchange as Finance Director, Chief Financial Officer and in a non-executive director capacity. Bevan is a Member of the Chartered Accountants – Australia and New Zealand, and he has a degree in Management Studies from the University of Waikato, New Zealand. Bevan was appointed to the Board of the Company on 18 December 2015.

Phil joined Microsaic Systems plc in 2014 as Engineering Manager, prior to being appointed Operations Director in 2017. Phil has held senior positions across fortune 500, medium and small-scale companies, operating in the high technology capital equipment sectors. Phil joined Microsaic from Oxford Instruments, Plasma Technology, a global provider of plasma tools used in the creation of MEMs devices, where he held the position of Engineering and Technology Director. Prior to this, Phil held senior positions, including programme management, New Product Introduction, Manufacturing Engineering and Operations at Applied Materials Inc.(Implant Division), a global leader in nano-manufacturing technology solutions and a supplier of semiconductor capital equipment,. A Graduate of the Warwick Manufacturing Group, he attained a Master’s Degree in Engineering Business Management and a First class BEng honors degree.

Richard joined Microsaic Systems in 2003 as a Product Engineer and progressed to Devices Manager. From 2006, he led a development team to make miniaturised, chip-based components using Micro-Electro-Mechanical Systems (MEMS) technology and has an extensive network of senior level relationships within micromachining fabs across the world. From 2010 he was Commercial manager supporting marketing-, sales- and servicing-related NPI activities of the MiD. Since 2016 Richard has moved into molecular diagnostics, establishing key strategic relationships with Biopharma. Between 2000 and 2003, Richard worked in various R&D and manufacturing sites at Agilent Technologies. He was awarded a BSc degree in Physics and Chemistry of Materials from the University of Durham, and obtained a PhD in Device Physics at the University of Cambridge.

Victoria joined Microsaic as applications engineer in 2015. Victoria has extensive knowledge in Mass Spectrometry, Liquid Chromatography-Mass Spectrometry (LC-MS), GMP and Analytical Chemistry.
Victoria graduated from Edinburgh University in 2013 where she was awarded a Masters in Chemistry. As part of her degree at Edinburgh she did a year in industry in their clinical applications lab at Waters and her masters project focused on the mass spectrometry of multimeric protein complexes. After graduating Victoria worked for Vista Analytical an environmental lab based in California doing environmental LCMS method development.

Steve Vigar has more than 20 years’ experience within the instrumentation industry, where he has held critical service roles in medical research and analytical instrumentation. Steve spent a significant time at Shimadzu, where he held the role of Regional Service manager for the UK. Steve joined Microsaic Systems plc, in July 2013 as Global Service Manager.

Steve has 25 years of research and development experience in both academic and commercial roles. Following a period at Applied Materials, a global equipment manufacturer, he joined Microsaic Systems in November 2003. Steve specialises in early-stage development of prototype systems, core technologies, MEMS devices, and novel applications. Steve was educated at the University of Southampton and subsequently held postdoctoral research positions at the Fritz Haber Institute, Berlin, the University of Southern Denmark, the University of Duisburg-Essen, and the University of Liverpool.

Bin has over 10 years’ both commercial and technical experience in analytical instruments. He has a broad range of experience across a range of analytical techniques such as IC, GC, ICP-MS, ICP-OES, AA and AFS, and specialises in Mass Directed analysis. A fluent speaker of Chinese, Bin is responsible for developing all business with OEM partners across APAC. Bin holds a PhD in Analytical Chemistry, Xiamen University in China, and he was awarded Alexander von Humboldt Fellowship when he held a postdoctoral position at Heidelberg University in Germany. In addition, Bin held the position of research fellow in the School of Public Health, at the University of Michigan.